Preoperative cyclooxygenase-2 inhibitor treatment reduces the incidence of heterotopic ossification after hip arthroplasty: six-month follow-up

Anesthesiology. 2007 Aug;107(2):358-9. doi: 10.1097/01.anes.0000271873.86164.74.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Arthroplasty, Replacement, Hip / adverse effects*
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Dinoprostone / biosynthesis
  • Drug Administration Schedule
  • Follow-Up Studies
  • Hip Joint / diagnostic imaging
  • Humans
  • Incidence
  • Lactones / therapeutic use*
  • Ossification, Heterotopic / prevention & control*
  • Postoperative Complications / prevention & control*
  • Preoperative Care / methods*
  • Radiography
  • Sulfones / therapeutic use*
  • Up-Regulation

Substances

  • Cyclooxygenase 2 Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib
  • Dinoprostone